Hong Kong stock anomaly | Quansheng Biology-B (02509.HK) surged more than 9% in the morning session. QX029N recently received clinical approval. QX030N previously reached an international licensing agreement.

According to the Zhitong Finance APP, Quintech Bio-B (02509.HK) surged more than 9% in the morning session, up 7.49% as of the time of writing, to 16.64 Hong Kong dollars, with a turnover of 9.4585 million Hong Kong dollars.